iCRT-14

CAS: 677331-12-3

Ref. 3D-FI24534

Produktinformation

• Name: iCRT-14
• Synonyme: 5-[[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedioneiCRT 14iCRT14

Beschreibung

iCRT-14 is a drug that has been shown to be effective in the treatment of a number of different diseases. It is a pluripotent cell therapy that is derived from skin cells which are grown and then induced to differentiate into other types of cells, such as cardiac cells. iCRT-14 has been shown to be capable of reversing the progression of some types of breast cancer by activating transcription-polymerase chain reaction (PCR) and increasing epidermal growth factor levels. The activation of cell signaling pathways, such as c-jun phosphorylation, also plays a role in iCRT-14's effect on cancer cells.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 375.44 g/mol
• Formel: C₂₁H₁₇N₃O₂S
• Reinheit: Min. 95%